Literature DB >> 522233

Experimental study of cardiomyopathy induced by glucocorticoids.

T Ito, M Murata, A Kamiyama.   

Abstract

Abnormal ECG changes were found in some patients who were treated glucocorticoid during long term. In experimental animals, chronic administration of glucocorticoid resulted abnormal ST and T changes of ECG, increased duration of action potential and induced electron microscopical changes of mitochondria. No significant changes were found in serum and myocardial potassium content.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 522233     DOI: 10.1253/jcj.43.1043

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  4 in total

1.  VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis.

Authors:  Blythe C Dillingham; Susan M Knoblach; Gina M Many; Brennan T Harmon; Amanda M Mullen; Christopher R Heier; Luca Bello; John M McCall; Eric P Hoffman; Edward M Connor; Kanneboyina Nagaraju; Erica K M Reeves; Jesse M Damsker
Journal:  Cell Mol Neurobiol       Date:  2014-11-13       Impact factor: 5.046

Review 2.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

3.  Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-beta.

Authors:  Haipeng Sun; Elena Sheveleva; Beibei Xu; Hiroyasu Inoue; Tim G Bowden; Qin M Chen
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

4.  VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice.

Authors:  Jesse M Damsker; Blythe C Dillingham; Mary C Rose; Molly A Balsley; Christopher R Heier; Alan M Watson; Erik J Stemmy; Roslyn A Jurjus; Tony Huynh; Kathleen Tatem; Kitipong Uaesoontrachoon; Dana M Berry; Angela S Benton; Robert J Freishtat; Eric P Hoffman; John M McCall; Heather Gordish-Dressman; Stephanie L Constant; Erica K M Reeves; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.